“…5,8,9 These and other studies suggest that risk factors for developing severe hepatotoxicity include concomitant use of multiple APAPcontaining products or other medicines that alter hepatic metabolism, delays in getting appropriate medical care, younger age, and a prodromal illness associated with periods of fasting. 4,5,8 Although the magnitude of this clinical problem in children is not well defined, 48% of APAP-induced ALF in adults in the United States is due to unintentional overdoses of APAP, often with the chronic use of ethanol or concomitant use of opioids or other potentially hepatotoxic medications, reinforcing the concept that accidental misuse of this medication leading to serious liver injury is a significant problem.…”